{{Rsnum
|rsid=3741920
|Gene=LEPREL2
|Chromosome=12
|position=6829708
|Orientation=plus
|GMAF=0.4513
|Gene_s=LEPREL2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 50.4 | 45.1 | 4.4
| HCB | 27.0 | 60.6 | 12.4
| JPT | 16.8 | 54.9 | 28.3
| YRI | 1.4 | 23.8 | 74.8
| ASW | 5.3 | 45.6 | 49.1
| CHB | 27.0 | 60.6 | 12.4
| CHD | 31.2 | 45.9 | 22.9
| GIH | 35.6 | 49.5 | 14.9
| LWK | 0.9 | 18.2 | 80.9
| MEX | 51.7 | 44.8 | 3.4
| MKK | 1.9 | 32.1 | 66.0
| TSI | 41.2 | 50.0 | 8.8
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22437554
|Trait=None
|Title=Genome-wide association study identifies three common variants associated with serologic response to vitamin E supplementation in men.
|RiskAllele=T
|Pval=0.000004
|OR=0.0400
|ORtxt=None
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}